The FDA is scheduled to hold a media availability to discuss FDA policies issued today to guide vaccines, diagnostic and therapeutic developers addressing COVID-19 virus variants. The media call is scheduled for Feb. 22, 2021, at 1:40 p.m. EST. Acting FDA Commissioner Janet Woodcock, M.D. and other senior leaders will be taking questions.
Media Call: COVID-19 Variant Guidances – 2/22/2021
